SCHEMBL7931904

SCHEMBL7931904

CC(C(C)(C(=O)O)c1ccncc1)P(=O)(O)Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
ANPEP P15144 1/20 0.37
ERAP2 Q6P179 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37
ALPL P05186 1/20 0.37
ALPI P09923 1/20 0.37
ALPG P10696 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MMP1 P03956 1/20 0.36
FDPS P14324 1/20 0.36
ENPEP Q07075 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
KIF11 P52732 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610487 0.75 ALPL (0.40) ALDH1A1CYP3A4ALPLALPIALPG
SCHEMBL7605689 0.74 RAB9A (0.40) ALDH1A1CYP3A4ALPLALPIALPG
SCHEMBL7605134 0.73 RAB9A (0.39) ANPEPERAP2ERAP1ALPLALPI
SCHEMBL7925747 0.72 FDPS (0.43) CYP3A4HTTSMN1; SMN2FDPSLMNA
SCHEMBL7929178 0.71 DHPS (0.38) ANPEPERAP2ERAP1MMP1ENPEP
SCHEMBL5058014 0.70 ERAP2 (0.48) ALDH1A1CYP3A4ANPEPERAP2ERAP1
SCHEMBL7926683 0.70 CETP (0.37) HTTSMN1; SMN2LMNAPOLB
SCHEMBL7606205 0.68 FDPS (0.43) ALDH1A1CYP3A4HTTFDPSLMNA
SCHEMBL7928411 0.68 MMP1 (0.40) ANPEPERAP2SMN1; SMN2MMP1
SCHEMBL7928566 0.68 MMP1 (0.34) MMP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP claimed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP claimed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO claimed
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP disclosed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP disclosed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO disclosed